Keipp Talbot Archives
Aug. 23, 2021—Listen to Episode 1, Blueprint for a Pandemic-Ready Society, and subscribe on your favorite platform. The first episode of the second season of Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, tackles bold questions and issues pushed to the surface by COVID-19. This season, the award-winning 10-episode series delves into...
Oct. 30, 2020—COVID-19 spreads faster and more widely throughout U.S. households than previously reported, according to new preliminary research from a multicenter study led by Vanderbilt University Medical Center researchers and published in, a weekly report from the Centers for Disease Control and Prevention (CDC).
Aug. 31, 2020—In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.
Jun. 30, 2020—Vanderbilt University Medical Center investigators are leading a new study that examines the transmission of SARS-CoV-2, the virus that causes COVID-19, within households in Nashville.
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
Mar. 1, 2018—An influenza diagnosis for people 65 and older is serious. Up to 85 percent of influenza-related deaths occur in older adults, the Centers for Disease Control (CDC) and Prevention reports.
Aug. 13, 2014—High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
Apr. 4, 2013—Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.